Pure Bioscience (PURE)
OTHER OTC:PURE
Holding PURE?
Track your performance easily

Pure Bioscience (PURE) Income Statement

40 Followers

Pure Bioscience Income Statement

Last quarter (Q4 2024), Pure Bioscience's total revenue was $474.00K, an increase of 16.46% from the same quarter last year. In Q4, Pure Bioscience's net income was $-756.00K. See Pure Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jul 24Jul 23Jul 22Jul 21Jul 20
Total Revenue
$ 1.96M$ 1.96M$ 1.88M$ 1.85M$ 3.93M$ 6.92M
Cost of Revenue
$ 811.00K$ 811.00K$ 906.00K$ 853.00K$ 1.85M$ 2.90M
Gross Profit
$ 1.15M$ 1.15M$ 971.00K$ 1.00M$ 2.08M$ 4.02M
Operating Expense
$ 4.34M$ 4.34M$ 4.91M$ 4.72M$ 4.39M$ 4.02M
Operating Income
$ -3.19M$ -3.19M$ -3.94M$ -3.72M$ -2.31M$ 4.00K
Net Non Operating Interest Income Expense
$ -103.00K-$ -14.00K$ -6.00K$ -4.00K$ -5.00K
Other Income Expense
$ 64.00K$ 64.00K$ 319.00K$ -115.00K$ 4.00K$ -5.00K
Pretax Income
$ -3.19M$ -3.19M$ -3.95M$ -3.49M$ -2.32M$ 4.00K
Tax Provision
--$ 1.65K$ 1.65K$ 1.65K$ 1.65K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -3.35M$ -3.35M$ -3.96M$ -3.49M$ -2.32M$ 4.00K
Basic EPS
$ -0.03$ -0.03$ -0.04$ -0.04$ -0.03-
Diluted EPS
$ -0.03$ -0.03$ -0.04$ -0.04$ -0.03-
Basic Average Shares
$ 447.43M$ 111.86M$ 111.40M$ 88.84M$ 87.17M$ 82.21M
Diluted Average Shares
$ 447.43M$ 111.86M$ 111.40M$ 88.84M$ 87.17M$ 84.61M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 5.15M$ 5.15M$ 5.82M$ 5.22M$ 6.24M$ 6.91M
Net Income From Continuing And Discontinued Operation
$ -3.35M$ -3.35M$ -3.96M$ -3.49M$ -2.32M$ 4.00K
Normalized Income
$ -3.04M$ -3.04M--$ -1.83M-
Interest Expense
------
EBIT
$ -3.25M$ -3.35M$ -3.96M$ -3.48M$ -2.31M$ 9.00K
EBITDA
$ -3.10M$ -3.20M$ -3.84M$ -3.27M$ -2.14M$ 201.00K
Currency in USD

Pure Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis